WINTON GROUP Ltd

Position in RGNX — REGENXBIO Inc.

CIK 1612063 LONDON, X0

Position in RGNX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$289,916

-$726,942 QoQ

Shares Held

24,200

-75.0% QoQ

Ownership

0.037%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#88

of 163 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

WINTON GROUP Ltd holds $97,029,578 across 91 Biotechnology names. RGNX ranks #48 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	254,408	$28,839,690
2	FTRE	Fortrea Holdings Inc.	389,155	$6,771,297
3	EXEL	Exelixis, Inc.	99,834	$5,431,967
4	TECH	BIO-TECHNE Corp	67,227	$4,749,587
5	HALO	Halozyme Therapeutics, Inc.	60,348	$4,723,437
6	VKTX	Viking Therapeutics, Inc.	90,546	$3,532,199
7	ALNY	Alnylam Pharmaceuticals, Inc.	7,880	$2,372,116
8	TRVI	Trevi Therapeutics, Inc.	106,852	$1,992,789

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$289,916	24,200	-75.0%	Shares	Sole	2026-08-07
2024-09-30	$1,016,858	96,936	+26.2%	Shares	Sole	2024-11-12
2024-06-30	$899,028	76,840	+79.9%	Shares	Sole	2024-08-09
2024-03-31	$899,773	42,704	+306.6%	Shares	Sole	2024-05-14
2023-03-31	$198,611	10,503	-73.9%	Shares	Sole	2023-05-12
2022-12-31	$914,366	40,316	+9.0%	Shares	Sole	2023-02-14
2022-09-30	$978,015	37,004	-18.1%	Shares	Sole	2022-11-10
2022-06-30	$1,115,600	45,166	+218.1%	Shares	Sole	2022-08-10
2022-03-31	$471,264	14,199	+18.5%	Shares	Sole	2022-05-11
2021-09-30	$502,453	11,986	-43.6%	Shares	Sole	2021-10-28
2020-06-30	$782,269	21,240	-78.2%	Shares	Sole	2020-08-05
2020-03-31	$3,156,402	97,480	—	Shares	Sole	2020-05-11
No filing history on record for this holder in this stock.